It was a busy week in the innovation arena, with several companies announcing the use of an expedited pathway.
Kiadis Pharma N.V. garnered a Regenerative Medicine Advanced Therapy (RMAT) designation for its ATIR101, highlighting the popularity of the RMAT...








